This inventor holds 3 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignee: Hanmi Pharm. Co., Ltd.. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Bo Sik Kim - Innovator in Pharmaceutical Formulations
Introduction
Bo Sik Kim is an inventor based in Seoul, South Korea. He is currently associated with Hanmi Pharmaceutical Co., Ltd. Although he has not yet been granted any patents, his work focuses on innovative pharmaceutical formulations. His contributions to the field are noteworthy, particularly in the development of composite formulations.
Latest Patent Applications
Bo Sik Kim has submitted several patent applications that showcase his innovative approach. One of his latest applications is titled "Composite Formulation Comprising Sitagliptin and Dapagliflozin and Preparation Method Therefor." This application provides a composite formulation that includes sitagliptin and dapagliflozin, along with a method for preparing the same. Another significant application is "Pharmaceutical Composite Formulation Comprising Proton Pump Inhibitor and Antacid, and Method for Preparing Same." This application details a pharmaceutical composite formulation that includes a first layer with a proton pump inhibitor and a second layer containing an antacid selected from magnesium hydroxide, magnesium oxide, or a mixture thereof.
Conclusion
Bo Sik Kim is making strides in the pharmaceutical industry through his innovative patent applications. His work has the potential to contribute significantly to the development of effective treatments.